Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) Enterprise Value (2020 - 2025)

Celularity has reported Enterprise Value over the past 6 years, most recently at -$120000.0 for Q3 2025.

  • Quarterly results put Enterprise Value at -$120000.0 for Q3 2025, up 9.77% from a year ago — trailing twelve months through Sep 2025 was -$120000.0 (up 9.77% YoY), and the annual figure for FY2024 was -$738000.0, down 225.11%.
  • Enterprise Value for Q3 2025 was -$120000.0 at Celularity, up from -$863000.0 in the prior quarter.
  • Over the last five years, Enterprise Value for CELU hit a ceiling of -$211.0 in Q2 2021 and a floor of -$73.3 million in Q3 2021.
  • Median Enterprise Value over the past 5 years was -$863000.0 (2025), compared with a mean of -$14.2 million.
  • Biggest five-year swings in Enterprise Value: tumbled 18007482.94% in 2022 and later soared 99.36% in 2023.
  • Celularity's Enterprise Value stood at -$37.2 million in 2021, then soared by 62.5% to -$14.0 million in 2022, then skyrocketed by 98.37% to -$227000.0 in 2023, then tumbled by 225.11% to -$738000.0 in 2024, then skyrocketed by 83.74% to -$120000.0 in 2025.
  • The last three reported values for Enterprise Value were -$120000.0 (Q3 2025), -$863000.0 (Q2 2025), and -$293000.0 (Q1 2025) per Business Quant data.